Search

Your search keyword '"Severi, Gianluca"' showing total 72 results

Search Constraints

Start Over You searched for: Author "Severi, Gianluca" Remove constraint Author: "Severi, Gianluca" Database Journals@OVID Remove constraint Database: Journals@OVID
72 results on '"Severi, Gianluca"'

Search Results

1. Association of DNA Methylation-Based Biological Age With Health Risk Factors and Overall and Cause-Specific Mortality

3. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types

4. Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study

5. Endometrial cancer risk prediction including serum‐based biomarkers: results from the EPIC cohort

7. Additive Interactions Between Susceptibility Single-Nucleotide Polymorphisms Identified in Genome-Wide Association Studies and Breast Cancer Risk Factors in the Breast and Prostate Cancer Cohort Consortium

8. A Prospective Study of the Immune System Activation Biomarker Neopterin and Colorectal Cancer Risk

9. Circulating Biomarkers of One-Carbon Metabolism in Relation to Renal Cell Carcinoma Incidence and Survival

10. Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study

11. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies1-3

12. Plasma fetuin-A concentration, genetic variation in the AHSG gene and risk of colorectal cancer

13. Further Confirmation of Germline Glioma Risk Variant rs78378222 in TP53 and Its Implication in Tumor Tissues via Integrative Analysis of TCGA Data

15. Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population

16. Anthropometric measures and bladder cancer risk: A prospective study in the EPIC cohort

17. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

18. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

19. Circulating 25-Hydroxyvitamin D3 in Relation to Renal Cell Carcinoma Incidence and Survival in the EPIC Cohort

20. Post-GWAS gene–environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79 000 women

22. Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies

23. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer

24. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium

26. Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression

27. Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis

28. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

29. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11

32. The role of genetic breast cancer susceptibility variants as prognostic factors

33. Association between adult height, genetic susceptibility and risk of glioma

34. 11q13 Is a Susceptibility Locus for Hormone Receptor Positive Breast Cancer

35. Interactions Between Genome-wide Significant Genetic Variants and Circulating Concentrations of Insulin-like Growth Factor 1, Sex Hormones, and Binding Proteins in Relation to Prostate Cancer Risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium

36. Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG

37. The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant

38. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium†

39. 7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium

40. The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and Spain

41. Genome-wide association study identifies new prostate cancer susceptibility loci

42. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium

44. Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

45. Genome-Wide Linkage Analysis of 1,233 Prostate Cancer Pedigrees From the International Consortium for Prostate Cancer Genetics Using Novel sum LINK and sum LOD Analyses

46. Association Between a Germline OCA2 Polymorphism at Chromosome 15q13.1 and Estrogen Receptor–Negative Breast Cancer Survival

48. Risk of Estrogen Receptor–Positive and –Negative Breast Cancer and Single–Nucleotide Polymorphism 2q35-rs13387042

49. Association of ESR1 gene tagging SNPs with breast cancer risk

50. Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer

Catalog

Books, media, physical & digital resources